ING Groep NV Has $24.87 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

ING Groep NV reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,311 shares of the biopharmaceutical company’s stock after selling 7,484 shares during the period. ING Groep […]

Related Keywords

Leonards Schleifer , ,Regeneron Pharmaceuticals ,Regeneron Pharmaceuticals Trading ,Stifel Financial Corp ,Regeneron Pharmaceuticals Inc ,Regeneron Pharmaceuticals Company Profile ,Monetary Management Group Inc ,Exchange Traded Concepts ,News Ratings For Regeneron Pharmaceuticals Daily ,Exchange Commission ,Meyer Handelman Co ,Quarter For Regeneron Pharmaceuticals ,Nasdaq ,Free Report ,Financial Corp ,Traded Concepts ,Monetary Management Group ,Management Group ,Visit Holdingschannel ,Regeneron Pharmaceuticals Daily ,